AbbVie’s Skyrizi narrowly slides ahead of J&J’s Tremfya in May drug ad spending rankings

AbbVie’s Skyrizi again held onto its top spot on the TV ad spender leaderboard for the month of May, but overall spend across the stable top three is falling. May saw a drug ad spending slump across the majority of the top ten drug ad spenders with AbbVie's Skyrizi and RInvoq, Johnson & Johnson's Tremfya and more all decreasing their monthly TV ad spend. Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Special Report Awards Gala Trending Oncology Supply Chain AI and Machine Learning Awards Outsourcing Awards…

Source: FiercePharma